日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Risk stratification for long-term inpatient costs in mental disorders: a dual-track machine learning approach using baseline EHRs and hospitalization trajectories

精神疾病长期住院费用风险分层:基于基线电子病历和住院轨迹的双轨机器学习方法

Zhang, Mengge; Pan, Guoliang; Shen, Haohui; He, Xiuwen; Xiang, Jingyi; Wang, Simeng; Yao, Mingyang; Yang, Yilong

Protein arginine methyltransferase 7-mediated arginine mono-methylation stabilizes SRY-box transcription factor 9 to promote non-small cell lung cancer progression.

蛋白质精氨酸甲基转移酶 7 介导的精氨酸单甲基化可稳定 SRY-box 转录因子 9,从而促进非小细胞肺癌的进展。

Zhang Lin, Xiang Jingyi, Feng Yali, Shen Gufang, Huang Xu, Fang Tianshu, Zhu Yunjia, Ren Hong, Liu Chungang

Strategic alliances and green innovation bubbles: drivers, distortions, and environmental consequences

战略联盟与绿色创新泡沫:驱动因素、扭曲因素及环境后果

Wang, Hongda; Xiang, Jingyi; Xie, Tianwei

A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML

一种具有抗体-T细胞受体(Ab-TCR)和共刺激受体的双受体T细胞平台,可实现对急性髓系白血病(AML)的特异性和高效性。

Dao, Tao; Xiong, Guangyan; Mun, Sung Soo; Meyerberg, Jeremy; Korontsvit, Tatyana; Xiang, Jingyi; Cui, Ziyou; Chang, Aaron Y; Jarvis, Casey; Cai, Winson; Luo, Hanzhi; Pierson, Aspen; Daniyan, Anthony; Yoo, Sarah; Takao, Sumiko; Kharas, Michael; Kentsis, Alex; Liu, Cheng; Scheinberg, David A

Determination of 14 Isoflavone Isomers in Natto by UPLC-ESI-MS/MS and Antioxidation and Antiglycation Profiles

通过 UPLC-ESI-MS/MS 测定纳豆中的 14 种异黄酮异构体及其抗氧化和抗糖化特性

Aoli Xiang, Jingyi Wang, Bijun Xie, Kai Hu, Mengting Chen, Zhida Sun

The landscape of RNA Pol II binding reveals a stepwise transition during ZGA

RNA Pol II 结合图谱揭示了 ZGA 过程中的逐步转变

Bofeng Liu #, Qianhua Xu #, Qiujun Wang #, Su Feng, Fangnong Lai, Peizhe Wang, Fangyuan Zheng, Yunlong Xiang, Jingyi Wu, Junwei Nie, Cui Qiu, Weikun Xia, Lijia Li, Guang Yu, Zili Lin, Kai Xu, Zhuqing Xiong, Feng Kong, Ling Liu, Chunyi Huang, Yang Yu, Jie Na, Wei Xie

Tanshinone IIA Reverses Oxaliplatin Resistance In Human Colorectal Cancer Via Inhibition Of ERK/Akt Signaling Pathway

丹参酮 IIA 通过抑制 ERK/Akt 信号通路逆转人类结直肠癌的奥沙利铂耐药性

Yonggang Zhang, Tingrui Ge, Ping Xiang, Jingyi Zhou, Shumin Tang, Haibing Mao, Qiang Tang

Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth

针对特定MUC16糖基化位点的抗体可抑制卵巢癌的生长

Rao, Thapi Dharma; Fernández-Tejada, Alberto; Axelrod, Abram; Rosales, Nestor; Yan, Xiujun; Thapi, Sahityasri; Wang, Amy; Park, Kay J; Nemieboka, Brandon; Xiang, Jingyi; Lewis, Jason S; Olvera, Narciso; Levine, Douglas A; Danishefsky, Samuel J; Spriggs, David R

Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1

靶向细胞内癌蛋白WT1的治疗性双特异性T细胞衔接抗体

Dao, Tao; Pankov, Dmitry; Scott, Andrew; Korontsvit, Tatyana; Zakhaleva, Victoriya; Xu, Yiyang; Xiang, Jingyi; Yan, Su; de Morais Guerreiro, Manuel Direito; Veomett, Nicholas; Dubrovsky, Leonid; Curcio, Michael; Doubrovina, Ekaterina; Ponomarev, Vladimir; Liu, Cheng; O'Reilly, Richard J; Scheinberg, David A

Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein

针对细胞内WT1癌蛋白的Fc增强型TCR样抗体的治疗效果

Veomett, Nicholas; Dao, Tao; Liu, Hong; Xiang, Jingyi; Pankov, Dmitry; Dubrovsky, Leonid; Whitten, Joseph A; Park, Sun-Mi; Korontsvit, Tatyana; Zakhaleva, Victoria; Casey, Emily; Curcio, Michael; Kharas, Michael G; O'Reilly, Richard J; Liu, Cheng; Scheinberg, David A